Mind and Matter

Research suggests that a combination of mental power and conventional medicine may be better than either alone.

Written byJo Marchant
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

CROWN, JANUARY 2016There are few questions as divisive in biomedical research as whether our thoughts can heal us. For skeptics, the very idea conjures visions of quacks peddling dodgy cures to desperate patients. Within the framework of conventional medicine, personal beliefs are a distraction, and drugs and other interventions are tested in rigorous clinical trials. Appointment times are kept to a minimum, and patients typically visit physicians looking for prescriptions, not reassuring chats. Surgeons certainly aren’t expected to inquire about their patients’ state of mind.

At the other extreme, alternative therapists (and presumably many of the millions of people who pay for their treatments) believe physical health is intimately entwined with one’s mental state. Most reject evidence-based treatments in favor of long, one-on-one consultations and insist that the mind’s healing power can’t be captured in impersonal trials. Western researchers and physicians are misguided, they say, for focusing so unwaveringly on drugs.

It can be hard to see any middle ground, but does the choice have to be so polarizing? In writing Cure: A Journey into the Science of Mind over Body, I visited researchers around the world who are investigating the role of the mind in health, and I concluded that both sides of the argument have got it wrong.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies